(Q35578049)

9 August 2017

1 reference

title

What is important in treating osteoarthritis? Whom should we treat and how should we treat them? (English)

1 reference

9 August 2017

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)00054-1

29 March 2024

1

Paul Dieppe

1 reference

9 August 2017

Kenneth D. Brandt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14603578

29 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14603578

29 March 2024

publication date

1 November 2003

1 reference

full work available at URL

9 August 2017

https://api.elsevier.com/content/article/PII:S0889857X03000541?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)00054-1

https://api.elsevier.com/content/article/PII:S0889857X03000541?httpAccept=text/plain

29 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)00054-1

Rheumatic Diseases Clinics of North America

29 March 2024

published in

1 reference

9 August 2017

volume

29

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

687-716

1 reference

Generalised osteoarthritis: an evolutionary problem?

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Osteoarthritis revisited and revived

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Emerging techniques for the discovery and validation of therapeutic targets for skeletal diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Innovative therapies in osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Epidemiology of research into interventions for the treatment of osteoarthritis of the knee joint

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Osteoarthritis: new insights. Part 1: the disease and its risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Occurrence of osteoarthritis of the peripheral joints in European populations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Epidemiology of knee injuries: diagnosis and triage

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Obesity in the United States: a fresh look at its high toll

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Quadriceps weakness and osteoarthritis of the knee.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Laxity in healthy and osteoarthritic knees

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

The prevention of type 2 diabetes--lifestyle change or pharmacotherapy? A challenge for the 21st century

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Diacerhein treatment reduces the severity of osteoarthritis in the canine cruciate-deficiency model of osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Glucosamine for osteoarthritis: magic, hype, or confusion? It's probably safe-but there's no good evidence that it works

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Contribution of meniscal extrusion and cartilage loss to joint space narrowing in osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Subchondral bone should be the main target for the treatment of pain and disease progression in osteoarthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Effectiveness and safety of strengthening, aerobic, and coordination exercises for patients with osteoarthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Radiographic assessment and psychologic variables as predictors of pain and functional impairment in osteoarthritis of the knee or hip.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Timing of total joint replacement affects clinical outcomes among patients with osteoarthritis of the hip or knee

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

1 reference

7 January 2021

Comparison of general internists, family physicians, and rheumatologists managing patients with symptoms of osteoarthritis of the knee.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Exploring the priorities of patients with osteoarthritis of the knee.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Paracetamol with and without codeine in acute pain: a quantitative systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Lack of efficacy of acetaminophen in treating symptomatic knee osteoarthritis: a randomized, double-blind, placebo-controlled comparison trial with diclofenac sodium

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

The incidence and natural history of knee osteoarthritis in the elderly, the framingham osteoarthritis study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Knee pain reduces joint space width in conventional standing anteroposterior radiographs of osteoarthritic knees

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Paracetamol in the treatment of osteoarthritis pain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Acetaminophen and Other Risk Factors for Excessive Warfarin Anticoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

The effects of acetaminophen on pharmacokinetics and pharmacodynamics of warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Acetaminophen, aspirin, and chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Comparative tolerability of paracetamol, aspirin and ibuprofen for short-term analgesia in patients with musculoskeletal conditions: results in 4291 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Determinants and sequelae associated with utilization of acetaminophen versus traditional nonsteroidal antiinflammatory drugs in an elderly population

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

n of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Closing in on a stomach-sparing aspirin substitute

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Efficacy and safety of eltenac gel in the treatment of knee osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Scope and impact of financial conflicts of interest in biomedical research: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Intraarticular injection of hyaluronan as treatment for knee osteoarthritis: what is the evidence?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Efficacy and safety of intraarticular sodium hyaluronate in knee osteoarthritis. ORTHOVISC Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

8 Intra-articular therapy in osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Aging, health risks, and cumulative disability

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Changes in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Supervised fitness walking in patients with osteoarthritis of the knee. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Effectiveness of home exercise on pain and disability from osteoarthritis of the knee: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Effects of a cross-training exercise program in persons with osteoarthritis of the knee a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Home based exercise programme for knee pain and knee osteoarthritis: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Effectiveness of exercise in patients with osteoarthritis of hip or knee: nine months' follow up

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Improvements in quadriceps sensorimotor function and disability of patients with knee osteoarthritis following a clinically practicable exercise regime.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Patient education interventions in osteoarthritis and rheumatoid arthritis: a meta-analytic comparison with nonsteroidal antiinflammatory drug treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Arthritis self-management studies: a twelve-year review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Reduction of joint pain in patients with knee osteoarthritis who have received monthly telephone calls from lay personnel and whose medical treatment regimens have remained stable

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

A controlled trial of arthroscopic surgery for osteoarthritis of the knee

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Débridement and Lavage for Osteoarthritis of the Knee

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Patient outcomes following unicompartmental or bicompartmental knee arthroplasty. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Does waiting for total hip replacement matter? Prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Loss to follow-up matters

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

Complementary and alternative medicine in rheumatology

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900054-1

7 January 2021

The increasing impact of arthritis on public health

16

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)00054-1

Preventing knee and hip osteoarthritis

29 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)00054-1

Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee

29 March 2024

34

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)00054-1

Over the counter non-steroidal anti-inflammatory drugs and risk of gastrointestinal bleeding

29 March 2024

54

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)00054-1

Treatment of knee osteoarthritis: relationship of clinical features of joint inflammation to the response to a nonsteroidal antiinflammatory drug or pure analgesic

29 March 2024

61

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)00054-1

29 March 2024

Celecoxib for arthritis

75

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)00054-1

Physical therapy is effective for patients with osteoarthritis of the knee: a randomized controlled clinical trial

29 March 2024

103

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)00054-1

Home based exercise therapy for older patients with knee osteoarthritis: a randomized clinical trial

29 March 2024

107

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)00054-1

29 March 2024

Identifiers

1 reference

9 August 2017

1 reference